303 related articles for article (PubMed ID: 16625170)
1. Handle with care.
Macilwain C
Nature; 2006 Apr; 440(7087):990-1. PubMed ID: 16625170
[No Abstract] [Full Text] [Related]
2. Perspectives. CMS and Wall Street report...
Med Health; 2003 Jan; 57(4):7-8. PubMed ID: 12602066
[No Abstract] [Full Text] [Related]
3. Going over the patent cliff.
Schommer JC
Minn Med; 2011 Oct; 94(10):42-3. PubMed ID: 23256283
[No Abstract] [Full Text] [Related]
4. Drug costs threaten patent protection.
Cimons M
Nat Med; 2003 Jan; 9(1):9. PubMed ID: 12514706
[No Abstract] [Full Text] [Related]
5. A change in the market--investing in diagnostics.
Batchelder K; Miller P
Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
[No Abstract] [Full Text] [Related]
6. Statin utilisation--recognising the role of the invisible hand.
Minhas R
Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171
[No Abstract] [Full Text] [Related]
7. Indian biogenerics industry emerges.
Jayaraman KS
Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
[No Abstract] [Full Text] [Related]
8. Reinventing an industry.
Mandavilli A
Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
[No Abstract] [Full Text] [Related]
9. [What drug companies actually do].
Tonby K
Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1806. PubMed ID: 17599137
[No Abstract] [Full Text] [Related]
10. [Free trade agreements make the drugs more expensive].
Jeppsson A
Lakartidningen; 2009 Nov 18-24; 106(47):3181. PubMed ID: 20082499
[No Abstract] [Full Text] [Related]
11. Pfizer slashes R&D.
Cressey D
Nature; 2011 Feb; 470(7333):154. PubMed ID: 21307908
[No Abstract] [Full Text] [Related]
12. Betting on biogenerics.
Dove A
Nat Biotechnol; 2001 Feb; 19(2):117-20. PubMed ID: 11175723
[No Abstract] [Full Text] [Related]
13. [Discount for only one drug of the same group leads to impaired health care quality].
Bergström R
Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044
[No Abstract] [Full Text] [Related]
14. Lowering the cost of prescription drugs.
Jindal B
J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276
[No Abstract] [Full Text] [Related]
15. A generic problem.
Hanauer SB
Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):649. PubMed ID: 17130869
[No Abstract] [Full Text] [Related]
16. Lilly goes off Prozac.
Simons J
Fortune; 2004 Jun; 149(13):179-80, 182, 184. PubMed ID: 15241951
[No Abstract] [Full Text] [Related]
17. Rx for investors.
Stires D
Fortune; 2004 May; 149(9):158-60, 162, 164 passim. PubMed ID: 15124332
[No Abstract] [Full Text] [Related]
18. SuperGenerics: a better alternative for biogenerics.
Charles SA
Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591
[No Abstract] [Full Text] [Related]
19. Prescription drug pushers. Patents and ads are the big reasons pills are priced like perfume and caviar.
Sherrid P
US News World Rep; 2000 Oct; 129(17):40-2. PubMed ID: 11184929
[No Abstract] [Full Text] [Related]
20. [Patients, patents and profits].
Roland PC
Tidsskr Nor Laegeforen; 2008 Jan; 128(2):205. PubMed ID: 18202741
[No Abstract] [Full Text] [Related]
[Next] [New Search]